SG49654A1 - The use of hyaluronic acid to repair ischemia reperfusion damage - Google Patents

The use of hyaluronic acid to repair ischemia reperfusion damage

Info

Publication number
SG49654A1
SG49654A1 SG1996002901A SG1996002901A SG49654A1 SG 49654 A1 SG49654 A1 SG 49654A1 SG 1996002901 A SG1996002901 A SG 1996002901A SG 1996002901 A SG1996002901 A SG 1996002901A SG 49654 A1 SG49654 A1 SG 49654A1
Authority
SG
Singapore
Prior art keywords
repair
hyaluronic acid
ischemia reperfusion
reperfusion damage
damage
Prior art date
Application number
SG1996002901A
Other languages
English (en)
Inventor
Rudolph Edgar Falk
Samuel Simon Asculai
Original Assignee
Hyal Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyal Pharma Corp filed Critical Hyal Pharma Corp
Publication of SG49654A1 publication Critical patent/SG49654A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG1996002901A 1992-02-20 1993-02-19 The use of hyaluronic acid to repair ischemia reperfusion damage SG49654A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002061567A CA2061567C (fr) 1992-02-20 1992-02-20 Utilisation de l'acide hyaluronique pour reparer les dommages de reperfusion de l'ischemie

Publications (1)

Publication Number Publication Date
SG49654A1 true SG49654A1 (en) 1998-06-15

Family

ID=4149301

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996002901A SG49654A1 (en) 1992-02-20 1993-02-19 The use of hyaluronic acid to repair ischemia reperfusion damage

Country Status (4)

Country Link
US (1) US5674857A (fr)
EP (1) EP0557118A1 (fr)
CA (1) CA2061567C (fr)
SG (1) SG49654A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834444A (en) * 1991-07-03 1998-11-10 Hyal Pharmaceutical Corporation Hyaluronic acid and salts thereof inhibit arterial restenosis
CA2130762C (fr) * 1994-08-24 1999-07-06 Eva Anne Turley Traitement des maladies et des troubles associes a l'infiltration par des macrophages
US5585361A (en) * 1994-06-07 1996-12-17 Genzyme Corporation Methods for the inhibition of platelet adherence and aggregation
US5591724A (en) * 1995-02-14 1997-01-07 Bioniche Inc. Method for treating the urinary bladder and associated structures using hyaluronic acid
JP4627580B2 (ja) * 2000-06-08 2011-02-09 生化学工業株式会社 肝疾患処置剤
ATE330468T1 (de) 2000-11-03 2006-07-15 Vitrolife Ab Lösung zur evaluierung und konservierung
US7544374B2 (en) * 2001-08-14 2009-06-09 Tel Aviv University Future Technology Development L.P. Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
US9241735B2 (en) 2003-12-05 2016-01-26 Onset Medical Corporation Expandable percutaneous sheath
EP1727564A1 (fr) * 2004-03-17 2006-12-06 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Cd44 comme cible pour la reduction/prevention des lesions consecutives a la perfusion ischemique
US7892203B2 (en) 2004-09-09 2011-02-22 Onset Medical Corporation Expandable transluminal sheath
US20060135962A1 (en) 2004-09-09 2006-06-22 Kick George F Expandable trans-septal sheath
WO2008079828A2 (fr) 2006-12-20 2008-07-03 Onset Medical Corporation Gaine transseptale dilatable
GB0913442D0 (en) 2009-07-31 2009-09-16 Univ Ramot Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
US20120208757A1 (en) * 2010-10-07 2012-08-16 Excel Med, Llc Use of hyaluronan for promoting angiogenesis
US9925143B2 (en) 2012-04-18 2018-03-27 Ramot At Tel-Aviv University Ltd. Lipidated glycosaminoglycan particles for the delivery of nucleic acids
WO2015198326A1 (fr) 2014-06-26 2015-12-30 Ramot At Tel-Aviv University Ltd. Formulations de liposome pour l'administration d'acides nucléiques
CN112972490B (zh) 2021-03-04 2022-02-18 中国人民解放军军事科学院军事医学研究院 透明质酸在用于制备预防或治疗铁死亡相关疾病的药物中的应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
US4684627A (en) * 1981-09-08 1987-08-04 Leveen Harry H Treatment of cancer with phlorizin and its derivatives
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
AU555747B2 (en) * 1983-08-09 1986-10-09 Cilco Inc. Chondroitin sulfate and sodium hyaluronate composition
IN163192B (fr) * 1983-10-11 1988-08-20 Fidia Spa
NO161573C (no) * 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
MX163953B (es) * 1984-03-27 1992-07-03 Univ New Jersey Med Procedimiento para preparar una matriz biodegradable a base de colageno
JPS6117A (ja) * 1984-06-11 1986-01-06 Seikagaku Kogyo Co Ltd ムコ多糖系癌転移抑制剤
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US4735902A (en) * 1984-10-23 1988-04-05 Matti Siren Stabilized composition containing inositoltriphosphate
US4636524A (en) * 1984-12-06 1987-01-13 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
DE3686275T2 (de) * 1985-01-11 1993-03-18 Teijin Ltd Praeparate mit verzoegerter freisetzung.
US4784990A (en) * 1985-01-18 1988-11-15 Bio-Technology General Corporation High molecular weight sodium hyaluronate
US4719201A (en) * 1985-02-07 1988-01-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
US4725585A (en) * 1985-04-26 1988-02-16 Pharmacia Ab Method of enhancing the host defense
DE3676235D1 (de) * 1985-06-04 1991-01-31 Teijin Ltd Arzneizubereitung mit verzoegerter wirkstoffabgabe.
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
FR2584606A1 (fr) * 1985-07-12 1987-01-16 Dropic Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif
IN166447B (fr) * 1985-11-27 1990-05-12 Ethicon Inc
EP0224987B1 (fr) * 1985-11-29 1992-04-15 Biomatrix, Inc. Systèmes à base de l'hyaluronanne, de ses dérivés et de ses sels pour la libération de médicaments et leur procédé de fabrication
JP2604135B2 (ja) * 1986-02-28 1997-04-30 ライオン株式会社 口腔骨疾患治療剤
EP0240098A3 (fr) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo et Polysaccharides pour le traitement des maladies causées par des rétrovirus
EP0244178A3 (fr) * 1986-04-28 1989-02-08 Iolab, Inc Compositions intraoculaires et leur procédé d'utilisation
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
IT1213301B (it) * 1986-07-14 1989-12-20 Zambon Spa Composizioni per il trattamento del le sindromi da ischemia e riperfusione
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
ZA878877B (en) * 1986-11-29 1988-05-24 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of diseases caused by viruses
GB8706052D0 (en) * 1987-03-13 1987-04-15 Medical Research Int Therapeutic compositions
EP0356435B1 (fr) * 1987-03-19 1995-10-18 Arthropharm Pty. Limited Composes et compositions anti-inflammatoires
EP0285357A3 (fr) * 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Lutte contre les rétrovirus
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
GB8713747D0 (en) * 1987-06-12 1987-07-15 Unilever Plc Skin treatment composition
US4931460A (en) * 1987-09-17 1990-06-05 E. R. Squibb & Sons, Inc. Post-ischemic myocardial dysfunction using thromboxane A2 antagonists
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US4968671A (en) * 1987-11-26 1990-11-06 Yamanouchi Pharmaceutical Co., Ltd. Therapeutic agents for ischemic heart diseases
US4988515A (en) * 1988-01-28 1991-01-29 The Regents Of The Univ. Of Calif. Cardioplegic solution
DK505588D0 (da) * 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
JPH01287041A (ja) * 1988-05-13 1989-11-17 Rooman Kogyo:Kk 徐放性製剤
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5057494A (en) * 1988-08-03 1991-10-15 Ethicon, Inc. Method for preventing tissue damage after an ischemic episode
CA1340994C (fr) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Traitement de maladies et d'etats pathologiques
US5095037B1 (en) * 1989-12-21 1995-12-19 Nissho Kk Combined anti-inflammatory agent
WO1991015215A1 (fr) * 1990-03-30 1991-10-17 Biomedical Frontiers, Inc. Technique de reanimation par administration de fluide
US5099012A (en) * 1990-12-11 1992-03-24 Eastman Kodak Company Chroman-2-carboxamide conjugates and their use for treatment of reperfusion injury
US5095027A (en) * 1991-02-28 1992-03-10 Clintec Nutrition Co. Method for treating reperfusion injury employing L-2-oxothiazolidine-4-carboxylic acid
DE19538814C2 (de) * 1995-10-18 1998-07-09 Obermaier Geb Ohg Fußmassagegerät

Also Published As

Publication number Publication date
CA2061567C (fr) 1998-02-03
CA2061567A1 (fr) 1993-08-21
EP0557118A1 (fr) 1993-08-25
US5674857A (en) 1997-10-07

Similar Documents

Publication Publication Date Title
ZA929709B (en) Method and composition for ameliorating tissue damage due to ischemia and reperfusion
GB9207624D0 (en) Improvements relating to the protection of corrosion-susceptible members
GB2292134B (en) Improvements relating to recipe additives in the form of retail units
GB9225925D0 (en) Improvements relating to cylinders
GB2281961B (en) Improvements in or relating to the movement of members
GB2279917B (en) Improvements relating to goods storage
ZA934948B (en) Improvements in or relating to spanners
GB2245235B (en) Improvements relating to trailers
GB9218718D0 (en) Improvements relating to carrings
GB9320667D0 (en) Line to panel coupling arrangement
GB9202450D0 (en) Improvements in or relating to kilns
GB9217910D0 (en) Improvements relating to storage arrangements
GB9206548D0 (en) Improvements in or relating to kilns
GB9316475D0 (en) Improvements in or relating to couplings
IL107829A0 (en) Improvement to capacitive coupled power supplies
GB2267467B (en) Improvements relating to trailers
GB2264634B (en) Improvements relating to racking
GB9212041D0 (en) Improvements relating to trailers
GB9216091D0 (en) Improvements in or relating to water supplies
GB9308176D0 (en) Improvements relating to towing arrangements
GB9208997D0 (en) Improvements in or relating to the fixing of bolts
GB9216366D0 (en) Improvement to boat fenders
GB9225876D0 (en) Improvements in or relating to trestle structures
IL105005A0 (en) Compositions for aiding in the regeneration of tissue with a prolonged immunomodulating effect
GB9206635D0 (en) Improvements in or relating to retroreflectors